"The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing," says first author Susan Domchek, MD.
OmniSeq Insight is a pan-cancer, solid tumor test that combines two different treatment paradigms: genomic and immune profiling.
Increased automation is needed more than ever to meet the ongoing demand for COVID-19 testing, particularly in small- and medium-size labs.
A new clinically-validated saliva test has been shown to detect HPV-associated head and neck cancer with high accuracy.
Researchers have found that saliva samples processed with a bead mill homogenizer before RT-PCR testing results in higher sensitivity.
As part of the agreement, EchelonDx is providing expertise using its precise PrenatalDx technology to help enhance the data analysis and reporting capabilities for Cradle’s comprehensive fetal genetic analysis and health screening solutions.
Automation using Nova View and the Nova Lite DAPI dsDNA Crithidia luciliae Kit can significantly improve laboratory turnaround time and reduce technician hands-on time.
New insight on the link between a gene called SORBS2 and congenital heart disease has been made and may help explain the cause of the disease.
Levels of NfL in the blood can identify those who might have neurodegenerative diseases when clinical symptoms are not definitive.
The InteliQ Diabetes Control includes three distinct levels that may address the HbA1c precision monitoring needs of a wide range of test methods.
Researchers from Boston University School of Medicine have developed a novel AI tool to predict the grade of IFTA for chronic kidney disease.
Researchers have discovered a key protein that helps the bacteria that causes Legionnaires’ disease to set up house hosts.
Findings confirm that T2 Biosystems’ magnetic resonance technology for identification of bloodstream infections provides faster time to detection and shorter hospital stays.